Published in J Clin Endocrinol Metab on February 01, 1998
Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis (2006) 1.42
Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study. BMC Public Health (2006) 1.03
Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients (2014) 0.88
Sex-specific dysregulation of cysteine oxidation and the methionine and folate cycles in female cystathionine gamma-lyase null mice: a serendipitous model of the methylfolate trap. Biol Open (2015) 0.76
The Effects of Muscle Mass on Homocyst(e)ine Levels in Plasma and Urine. Int J Exerc Sci (2012) 0.75
Differential effect of female gender on coronary artery disease and peripheral artery disease. Neth Heart J (2002) 0.75
Interactions between lifestyle and MTHFR polymorphisms on homocysteine concentrations in young adults belonging to the 1982 Pelotas Birth Cohort. Eur J Clin Nutr (2016) 0.75
PCOS women show significantly higher homocysteine level, independent to glucose and E2 level. Int J Reprod Biomed (Yazd) (2016) 0.75
Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem (2017) 0.75
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26
Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15
Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol (1998) 2.09
Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res (1999) 2.00
Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) (1997) 1.90
[Clinical judgment and decision in practice. A patient with dyspnea]. Ned Tijdschr Geneeskd (1996) 1.71
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia (1999) 1.67
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries. Cardiovasc Res (1999) 1.54
Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51
Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia (2008) 1.48
[Periodic fever due to hyper-IgD syndrome]. Ned Tijdschr Geneeskd (2000) 1.48
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46
Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens (1995) 1.44
Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44
Birth order and sibling sex ratio in two samples of Dutch gender-dysphoric homosexual males. Arch Sex Behav (1996) 1.43
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol (1998) 1.42
Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation (1999) 1.42
Influence of sex hormones on plasma endothelin levels. Ann Intern Med (1993) 1.40
[Primary hyperaldosteronism as a cause of hypertension; diagnosis]. Ned Tijdschr Geneeskd (1996) 1.40
Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clin Endocrinol (Oxf) (1995) 1.40
[Clinical judgment and decision making in clinical practice. A patient with fever and neck pain]. Ned Tijdschr Geneeskd (1996) 1.39
An epidemiological and demographic study of transsexuals in The Netherlands. Arch Sex Behav (1996) 1.38
Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl) (1998) 1.31
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Comparison of blood pressure measurement methods. Lancet (1997) 1.29
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab (2001) 1.25
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol (1999) 1.21
In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab (2000) 1.14
Increased plasma homocysteine after menopause. Atherosclerosis (2000) 1.14
The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care (1998) 1.14
The prevalence of transsexualism in The Netherlands. Acta Psychiatr Scand (1993) 1.13
Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension (2001) 1.13
[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 1.10
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology (1991) 1.10
Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol (2001) 1.09
Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia (1998) 1.08
Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res (2001) 1.07
Determinants of the limits of agreement between the sphygmomanometer and the SpaceLabs 90207 device for blood pressure measurement in health volunteers and insulin-dependent diabetic patients. J Hypertens (1998) 1.07
Menopausal status and risk factors for cardiovascular disease. J Intern Med (1999) 1.05
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol (2005) 1.04
Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study. Diabet Med (2008) 1.04
Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant (1997) 1.04
Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review. Asian J Androl (2000) 1.04
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl (2005) 1.03
Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab (1997) 1.02
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care (1999) 1.01
Reproducibility of fat area measurements in young, non-obese subjects by computerized analysis of magnetic resonance images. Int J Obes Relat Metab Disord (1997) 1.01
Facial corrections in male to female transsexuals: a preliminary report on 16 patients. J Oral Maxillofac Surg (1996) 1.01
Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab (1988) 1.00
Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology (1995) 1.00
Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant (1998) 1.00
Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant (1997) 0.99
Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia (2000) 0.99
Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost (2000) 0.99
Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med (2000) 0.99
Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care (1999) 0.99
Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med (1998) 0.98
Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 0.98
Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med (1993) 0.97
Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus? J Intern Med (1997) 0.96
Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg (1994) 0.96
Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism (1999) 0.96
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol (2001) 0.96
Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab (1997) 0.96
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia (2013) 0.96
Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care (2000) 0.95
Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol (1998) 0.95
Hyperproinsulinaemia in impaired glucose tolerance is associated with a delayed insulin response to glucose. Diabetologia (1999) 0.95
The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost (1998) 0.95
Androgens and ankylosing spondylitis: a role in the pathogenesis? Ann N Y Acad Sci (1999) 0.94
Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis (1998) 0.94